Analytic Investors’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
$406K Buy
17,113
+3,051
+22% +$76.6K ﹤0.01% 502
2016
Q2
$365K Hold
14,062
﹤0.01% 504
2016
Q1
$360K Buy
14,062
+2,539
+22% +$56.9K ﹤0.01% 518
2015
Q4
$228K Buy
+11,523
New +$234K ﹤0.01% 591
2015
Q3
Sell
-844,458
Closed -$18.9M 581
2015
Q2
$18.9M Sell
844,458
-2,647
-0.3% -$63.4K 0.27% 93
2015
Q1
$20.3M Sell
847,105
-97,557
-10% -$2.42M 0.28% 94
2014
Q4
$25M Sell
944,662
-2,105,228
-69% -$54M 0.36% 86
2014
Q3
$74.2M Buy
3,049,890
+673,766
+28% +$15.8M 1.06% 23
2014
Q2
$61.8M Sell
2,376,124
-380,933
-14% -$9.71M 1% 32
2014
Q1
$66M Buy
2,757,057
+2,697,196
+4,506% +$56.8M 1% 28
2013
Q4
$1.17M Buy
59,861
+29,832
+99% +$600K 0.02% 299
2013
Q3
$635K Sell
30,029
-181,948
-86% -$3.98M 0.01% 343
2013
Q2
$4.67M Buy
+211,977
New +$5.14M 0.08% 205

Other funds holding EXC

Analytic Investors's EXC Position: Q3 2016 in Review

Analytic Investors increased its Exelon (EXC) stake by 22% in Q3 2016, buying an estimated $76.6K and bringing the position to 17,113 shares worth $406K. The position accounts for ﹤0.01% of the portfolio, ranked #502.

Analytic Investors first reported a position in EXC in Q2 2013 and has held it in 13 quarters since. The position peaked at $74.2M in Q3 2014. 749 funds tracked by Wall St. Rank hold EXC as of Q3 2016.

  • Analytic Investors held 17,113 shares of Exelon worth $406K as of Q3 2016.
  • Analytic Investors bought 3,051 Exelon shares in Q3 2016, an estimated $76.6K.
  • Exelon made up ﹤0.01% of Analytic Investors's portfolio in Q3 2016, its #502 holding.
  • Analytic Investors first reported a position in Exelon in Q2 2013 and has held it in 13 quarters since.
  • Analytic Investors's Exelon position peaked at $74.2M in Q3 2014.
  • 749 funds tracked by Wall St. Rank held Exelon as of Q3 2016.

Based on Analytic Investors's 13F filing for Q3 2016, filed 14 Nov 2016.